• About us
• Contact

Advertisement

Organisation › Details

Concept Life Sciences (Group)

Concept Life Sciences provides integrated, high quality drug discovery, development and analytical services to the life science sector. Formed as a result of targeted acquisition and organic growth, the Company has the in-house expertise and resource to support customers with projects spanning from target discovery to the clinic, adding value and IP throughout the discovery pathway. With a track record of delivering knowledge-based, science-led solutions, the Company employs over 700 FTEs, including more than 500 highly skilled, experienced scientists, supporting its global client base from 11 state of the art laboratory facilities. Concept Life Sciences has worked with all of the top 10 pharma and biotech companies, and is targeting revenues exceeding $60m in 2017. Having experienced rapid growth, the Company remains focused on problem solving, quality, collaboration, and flexibility. Concept Life Sciences was formed in 2014 with backing from private equity firm Equistone Partners Europe. *

 

	Start	2014-01-01 established
	Group	Spectris (Group)
	Industry	drug discovery services
	Industry 2	analytical services
	Person	Fort, Michael (Concept Life Sciences 201708 Executive Chairman)
	Region	Manchester, Greater Manchester
	Country	United Kingdom (GB)
	Street	19 Spring Gardens 4th Floor
	City	M2 1FB Manchester
		Address record changed: 2024-01-05
Basic data	Employees	E: 501 to 1,000 (2017-07-19)
	Currency	USD
	Annual sales	60,000,000 (revenues, planned (2017) 2017-12-31)
		* Document for »About Section«: Concept Life Sciences Holdings Ltd.. (1/26/18). "Press Release: Concept Life Sciences Group Acquired by Spectris plc". Manchester & Egham.
		Record changed: 2023-07-10

Advertisement

More documents for Spectris (Group)

• [1] Charnwood Molecular Ltd.. (6/30/22). "Press Release: Lee Patterson Appointed as New CEO of Charnwood Molecular"....
• [2] Malvern Panalytical B.V.. (1/14/22). "Press Release: Malvern Panalytical Inc. and TA Instruments-Waters LLC Agree to Partial Settlement of Patent Infringement Lawsuit". Almelo....
• [3] Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix"....
• [4] Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern....
• [5] Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden....
• [6] Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich)....
• [7] Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich)....
• [8] Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich)....
• [9] Creoptix AG. (9/5/18). "Press Release: Creoptix Attracts Waters as Corporate Investor". Wädenswil (Zurich)....
• [10] Concept Life Sciences Holdings Ltd.. (1/26/18). "Press Release: Concept Life Sciences Group Acquired by Spectris plc". Manchester & Egham....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.